NEW YORK (GenomeWeb News) - Neuromed has licensed an Aureus Pharma database for use in its drug-development programs, Aureus said today.
Under the agreement, Neuromed will use the company’s AurScope Ion Channel database to support development of its chronic pain drugs.
AurScope contains information from the scientific literature that can be used to study "all known" ion channels that apply to "all stages of the drug discovery process," Aureus said.
Financial terms of the agreement were not released.